Chemoinformaics analysis of 1-(4-Hydroxy-3-methoxyphenyl)dodecan-3-one
| Molecular Weight | 306.446 | nRot | 12 |
| Heavy Atom Molecular Weight | 276.206 | nRig | 7 |
| Exact Molecular Weight | 306.219 | nRing | 1 |
| Solubility: LogS | -4.513 | nHRing | 0 |
| Solubility: LogP | 4.803 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 54.1398 |
| nHD | 1 | BPOL | 32.7002 |
| QED | 0.55 |
| Synth | 1.969 |
| Natural Product Likeliness | 0.893 |
| NR-PPAR-gamma | 0.967 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.977 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.743 |
| MDCK | 0.0000152 |
| BBB | 0.861 |
| PPB | 0.979299 |
| VDSS | 1.24 |
| FU | 0.00881007 |
| CYP1A2-inh | 0.834 |
| CYP1A2-sub | 0.869 |
| CYP2c19-inh | 0.765 |
| CYP2c19-sub | 0.335 |
| CYP2c9-inh | 0.498 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.721 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.71 |
| CYP3a4-sub | 0.155 |
| CL | 10.336 |
| T12 | 0.867 |
| hERG | 0.14 |
| Ames | 0.06 |
| ROA | 0.042 |
| SkinSen | 0.731 |
| Carcinogencity | 0.062 |
| EI | 0.952 |
| Respiratory | 0.83 |
| NR-Aromatase | 0.374 |
| Antiviral | Yes |
| Prediction | 0.636838 |